The Superiority of T2*MRI Over Serum Ferritin in the Evaluation of Secondary Iron Overload in a Chronic Kidney Disease Patient: A Case Report

References

• Cook JD, Flowers CH, Skikne BS. The quantitative assessment of body iron. Blood. 2003;101(9):3359–3364. Epub 2003 Jan 9. PMID: 12521995. doi:10.1182/blood-2002-10-3071
   Web of Science ®Google Scholar
• McLaren GD, Muir WA, Kellermeyer RW. Iron overload disorders: natural history, pathogenesis, diagnosis, and therapy. Crit Rev Clin Lab Sci. 1983;19(3):205–266. PMID: 6373141. doi:10.3109/10408368309165764
   PubMed Web of Science ®Google Scholar
• Siddique A, Kowdley KV. Review article: the iron overload syndromes. Aliment Pharmacol Ther. 2012;35(8):876–893. Epub 2012 Mar 4. PMID: 22385471. doi:10.1111/j.1365-2036.2012.05051.x
   PubMed Web of Science ®Google Scholar
• Khan AM, Al-Sulaiti AM, Younes S, Yassin M, Zayed H. The spectrum of beta-thalassemia mutations in the 22 Arab countries: a systematic review. Expert Rev Hematol. 2021;14(1):109–122. Epub 2020 Dec 29. PMID: 33317346. doi:10.1080/17474086.2021.1860003
   PubMed Web of Science ®Google Scholar
• Yassin M, Soliman A, De Sanctis V, et al. Liver iron content (LIC) in adults with sickle cell disease (SCD): correlation with serum ferritin and liver enzymes concentrations in trasfusion dependent (TD-SCD) and non-transfusion dependent (NT-SCD) patients. Mediterr J Hematol Infect Dis. 2017;9(1):e2017037. PMID: 28698780; PMCID: PMC5499497. doi:10.4084/MJHID.2017.037
   Web of Science ®Google Scholar
• Cullis JO, Fitzsimons EJ, Griffiths WJ, Tsochatzis E, Thomas DW; British Society for Haematology. Investigation and management of a raised serum ferritin. Br J Haematol. 2018;181(3):331–340. Epub 2018 Apr 19. PMID: 29672840. doi:10.1111/bjh.15166
   PubMed Web of Science ®Google Scholar
• Yassin M, Soliman AT, De Sanctis V, Moustafa A, Samaan SA, Nashwan A. A young adult with unintended acute intravenous iron intoxication treated with oral chelation: the use of liver ferriscan for diagnosing and monitoring tissue iron load. Mediterr J Hematol Infect Dis. 2017;9(1):e2017008. PMID: 28101313; PMCID: PMC5224804. doi:10.4084/MJHID.2017.008
   Web of Science ®Google Scholar
• Rostoker G, Vaziri ND, Fishbane S. Iatrogenic iron overload in dialysis patients at the beginning of the 21st century. Drugs. 2016;76(7):741–757. PMID: 27091216; PMCID: PMC4848337. doi:10.1007/s40265-016-0569-0
   PubMed Web of Science ®Google Scholar
• Aldwairi MM, Yassin MA. Iatrogenic iron overload in an end stage renal disease patient. Case Rep Oncol. 2020;13(2):760–763. PMID: 32774272; PMCID: PMC7383200. doi:10.1159/000507979
   Web of Science ®Google Scholar
• Kanbour I, Chandra P, Soliman A, et al. Severe liver iron concentrations (LIC) in 24 patients with β-thalassemia major: correlations with serum ferritin, liver enzymes and endocrine complications. Mediterr J Hematol Infect Dis. 2018;10(1):e2018062. PMID: 30416694; PMCID: PMC6223579. doi:10.4084/MJHID.2018.062
   Web of Science ®Google Scholar
• Yassin MA, Soliman A, De Sanctis V, et al. The impact of iron overload in patients with acute leukemia and myelodysplastic syndrome on hepatic and endocrine functions. Acta Biomed. 2018;89(3–S):18–22. PMID: 29633728; PMCID: PMC6179097. doi:10.23750/abm.v89i3-S.7213
   Google Scholar
• Ali M, Okar L, Iqbal P, Yassin MA. Iatrogenic iron overload in a patient with chronic kidney disease: is there a correlation between serum ferritin and liver iron concentration determined by MRI T2*? Cureus. 2020;12(6):e8914. PMID: 32742880; PMCID: PMC7389957. doi:10.7759/cureus.8914
   Web of Science ®Google Scholar
• Wish JB, Aronoff GR, Bacon BR, et al. Positive iron balance in chronic kidney disease: how much is too much and how to tell? Am J Nephrol. 2018;47(2):72–83. Epub 2018 Feb 13. PMID: 29439253. doi:10.1159/000486968
   PubMed Web of Science ®Google Scholar
• Le Lan C, Loréal O, Cohen T, et al. Redox active plasma iron in C282Y/C282Y hemochromatosis. Blood. 2005;105(11):4527–4531. Epub 2005 Jan 25. PMID: 15671444. doi:10.1182/blood-2004-09-3468
   PubMed Web of Science ®Google Scholar
• Soliman A, Yassin M, Al Yafei F, et al. Longitudinal study on liver functions in patients with thalassemia major before and after deferasirox (DFX) therapy. Mediterr J Hematol Infect Dis. 2014;6(1):e2014025. PMID: 24803998; PMCID: PMC4010606. doi:10.4084/MJHID.2014.025
   PubMedGoogle Scholar
• Rostoker G, Vaziri ND. Iatrogenic iron overload and its potential consequences in patients on hemodialysis. Presse Med. 2017;46(12 Pt 2):e312–e328. Epub 2017 Nov 16. PMID: 29153377. doi:10.1016/j.lpm.2017.10.014
   PubMed Web of Science ®Google Scholar
• Gaenzer H, Marschang P, Sturm W, et al. Association between increased iron stores and impaired endothelial function in patients with hereditary hemochromatosis. J Am Coll Cardiol. 2002;40(12):2189–2194. PMID: 12505233. doi:10.1016/s0735-1097(02)02611-6
   PubMed Web of Science ®Google Scholar
• Reis KA, Guz G, Ozdemir H, et al. Intravenous iron therapy as a possible risk factor for atherosclerosis in end-stage renal disease. Int Heart J. 2005;46(2):255–264. PMID: 15876809. doi:10.1536/ihj.46.255
   PubMed Web of Science ®Google Scholar
• Angelucci E, Brittenham GM, McLaren CE, et al. Hepatic iron concentration and total body iron stores in thalassemia major. N Engl J Med. 2000;343(5):327–331. Erratum in: N Engl J Med 2000 Dec 7;343(23):1740.PMID: 10922422. doi:10.1056/NEJM200008033430503
   PubMed Web of Science ®Google Scholar
• Fischer R, Harmatz PR. Non-invasive assessment of tissue iron overload. Hematology Am Soc Hematol Educ Program. 2009:2009:215–221. PMID: 20008201. doi:10.1182/asheducation-2009.1.215
   Google Scholar
• Lyle L, Hirose A. Iron overload in myelodysplastic syndromes: pathophysiology, consequences, diagnosis, and treatment. J Adv Pract Oncol. 2018;9(4):392–405. Epub 2018 May 1. PMID: 30719392; PMCID: PMC6347085.
   Google Scholar
• Canavese C, Bergamo D, Ciccone G, et al. Validation of serum ferritin values by magnetic susceptometry in predicting iron overload in dialysis patients. Kidney Int. 2004;65(3):1091–1098. PMID: 14871430. doi:10.1111/j.1523-1755.2004.00480.x
   PubMed Web of Science ®Google Scholar
• Ferrari P, Kulkarni H, Dheda S, et al. Serum iron markers are inadequate for guiding iron repletion in chronic kidney disease. Clin J Am Soc Nephrol. 2011;6(1):77–83. Epub 2010 Sep 28. PMID: 20876673; PMCID: PMC3022252. doi:10.2215/CJN.04190510
   PubMed Web of Science ®Google Scholar
• Ghoti H, Rachmilewitz EA, Simon-Lopez R, et al. Evidence for tissue iron overload in long-term hemodialysis patients and the impact of withdrawing parenteral iron. Eur J Haematol. 2012;89(1):87–93. Epub 2012 May 18. PMID: 22435497. doi:10.1111/j.1600-0609.2012.01783.x
   PubMed Web of Science ®Google Scholar
• Rostoker G, Griuncelli M, Loridon C, et al. Reassessment of iron biomarkers for prediction of dialysis iron overload: an MRI Study. PLoS One. 2015;10(7):e0132006. PMID: 26182077; PMCID: PMC4504469. doi:10.1371/journal.pone.0132006
   PubMed Web of Science ®Google Scholar